CN111529716B - 一种多肽-紫杉醇偶联物及其应用 - Google Patents
一种多肽-紫杉醇偶联物及其应用 Download PDFInfo
- Publication number
- CN111529716B CN111529716B CN202010488241.0A CN202010488241A CN111529716B CN 111529716 B CN111529716 B CN 111529716B CN 202010488241 A CN202010488241 A CN 202010488241A CN 111529716 B CN111529716 B CN 111529716B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- paclitaxel
- conjugate
- paclitaxel conjugate
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010488241.0A CN111529716B (zh) | 2020-06-02 | 2020-06-02 | 一种多肽-紫杉醇偶联物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010488241.0A CN111529716B (zh) | 2020-06-02 | 2020-06-02 | 一种多肽-紫杉醇偶联物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111529716A CN111529716A (zh) | 2020-08-14 |
CN111529716B true CN111529716B (zh) | 2021-05-28 |
Family
ID=71974212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010488241.0A Active CN111529716B (zh) | 2020-06-02 | 2020-06-02 | 一种多肽-紫杉醇偶联物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529716B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112321684B (zh) * | 2020-11-03 | 2022-09-20 | 红河学院 | 紫杉醇-抗菌肽偶合物、合成方法、抑制癌症活性的应用 |
CN113527412A (zh) * | 2021-07-14 | 2021-10-22 | 浙江紫杉泰生物科技有限公司 | 一种生物活性肽溶液生产设备及制作工艺 |
CN114404417B (zh) * | 2022-02-24 | 2023-06-13 | 广东晨康生物科技有限公司 | 一种枝状多肽-喜树碱药物偶联物及其制备方法和应用 |
CN114533893A (zh) * | 2022-02-25 | 2022-05-27 | 天津医科大学总医院 | 一种具有抗胶质瘤活性的与多肽偶联的紫杉醇的制备方法 |
CN116251195B (zh) * | 2022-12-27 | 2023-12-05 | 哈尔滨吉象隆生物技术有限公司 | 一种紫杉醇靶向肽偶联物及其应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1033372A1 (en) * | 1997-11-18 | 2000-09-06 | Chugai Seiyaku Kabushiki Kaisha | Compounds with antitumor activity |
CN101262890A (zh) * | 2005-07-15 | 2008-09-10 | 安吉奥化学公司 | 抑肽酶多肽作为载体在药物缀合物中的用途 |
CN101357939A (zh) * | 2008-09-11 | 2009-02-04 | 中国药科大学 | 蛋白质偶联物及其药物组合物 |
CN103784406A (zh) * | 2014-01-20 | 2014-05-14 | 同济大学 | 一种偶联穿膜肽和mmp酶切位点的纳米颗粒 |
CN103805621A (zh) * | 2013-12-21 | 2014-05-21 | 中国人民解放军军事医学科学院军事兽医研究所 | 靶向性抗肿瘤融合蛋白质lpo的新型制备工艺 |
WO2014204856A1 (en) * | 2013-06-17 | 2014-12-24 | Catabasis Pharmaceuticals, Inc. | Fatty acid anticancer derivatives and their uses |
CN110179994A (zh) * | 2019-04-30 | 2019-08-30 | 北京大学 | 一种温度和酶双重响应性蛋白质高分子偶联物及其制备方法与应用 |
CN110314238A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种肿瘤靶向的多肽药物偶联物及其制备方法和应用 |
CN110314237A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种还原响应型肿瘤靶向多肽药物偶联物及其制备方法和应用 |
CN111110858A (zh) * | 2018-10-31 | 2020-05-08 | 烟台药物研究所 | 一种Her2靶向的多肽药物偶联物及其制备方法和应用 |
-
2020
- 2020-06-02 CN CN202010488241.0A patent/CN111529716B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1033372A1 (en) * | 1997-11-18 | 2000-09-06 | Chugai Seiyaku Kabushiki Kaisha | Compounds with antitumor activity |
CN101262890A (zh) * | 2005-07-15 | 2008-09-10 | 安吉奥化学公司 | 抑肽酶多肽作为载体在药物缀合物中的用途 |
CN101357939A (zh) * | 2008-09-11 | 2009-02-04 | 中国药科大学 | 蛋白质偶联物及其药物组合物 |
WO2014204856A1 (en) * | 2013-06-17 | 2014-12-24 | Catabasis Pharmaceuticals, Inc. | Fatty acid anticancer derivatives and their uses |
CN103805621A (zh) * | 2013-12-21 | 2014-05-21 | 中国人民解放军军事医学科学院军事兽医研究所 | 靶向性抗肿瘤融合蛋白质lpo的新型制备工艺 |
CN103784406A (zh) * | 2014-01-20 | 2014-05-14 | 同济大学 | 一种偶联穿膜肽和mmp酶切位点的纳米颗粒 |
CN110314238A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种肿瘤靶向的多肽药物偶联物及其制备方法和应用 |
CN110314237A (zh) * | 2018-03-30 | 2019-10-11 | 烟台药物研究所 | 一种还原响应型肿瘤靶向多肽药物偶联物及其制备方法和应用 |
CN111110858A (zh) * | 2018-10-31 | 2020-05-08 | 烟台药物研究所 | 一种Her2靶向的多肽药物偶联物及其制备方法和应用 |
CN110179994A (zh) * | 2019-04-30 | 2019-08-30 | 北京大学 | 一种温度和酶双重响应性蛋白质高分子偶联物及其制备方法与应用 |
Non-Patent Citations (4)
Title |
---|
Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation;Xiaoyan Zhang等;《International Journal of Nanomedicine》;20160422;第11卷;第1643-1661页 * |
Synthesis and antitumor activity of peptide-paclitaxel conjugates;Serafim Papas等;《Journal of Peptide Science》;20071231;第13卷;第662-671页 * |
The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system;F. He等;《Acta Pharm Sin》;20151231;第50卷;第141-147页 * |
肿瘤靶向肽偶联药物的研究进展;刘巾玮,等;《中国新药与临床杂志》;20200331;第39卷(第3期);第129-134页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111529716A (zh) | 2020-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111529716B (zh) | 一种多肽-紫杉醇偶联物及其应用 | |
CN100427502C (zh) | 抗肿瘤寡肽及其制备方法和应用 | |
CN104370862B (zh) | 水溶性抗肿瘤化合物 | |
CN111718395B (zh) | 一种前药激活化合物、前药体系及其制备方法和应用 | |
CN111574592B (zh) | 一类具有拮抗pd-1/pd-l1相互作用的环肽类化合物及其应用 | |
CN102731573A (zh) | 布雷菲德菌素a的羟基磷酸氨基酸酯类衍生物及其制备方法和应用 | |
CN116251195B (zh) | 一种紫杉醇靶向肽偶联物及其应用 | |
CN111606975B (zh) | 从棕色扁海绵中提取的环肽类化合物及其制备方法与用途 | |
US20050032707A1 (en) | Novel peptides comprising furanoid sugar amino acids for the treatment of cancer | |
CN113583088A (zh) | 用于治疗胃癌的环肽及其药物组合物 | |
CN114404417B (zh) | 一种枝状多肽-喜树碱药物偶联物及其制备方法和应用 | |
CN106905414B (zh) | 新放线菌素a及其制备方法和用途 | |
CN110240631A (zh) | 手性异吲哚酮并环六肽衍生物、其制备办法及用途 | |
CN114380886B (zh) | 一种肿瘤靶向多肽、多肽偶联药物及其应用 | |
CN109248324A (zh) | GnRH类似物-抗肿瘤药物偶联物、其制备方法及用途 | |
CN111423497B (zh) | 拮抗肽、其共聚物及纳米组装体、及其制备方法和应用 | |
CN105879040B (zh) | 聚天冬酰-rgdf-抗肿瘤药物复合物的制备和应用 | |
EP2405944B1 (en) | Prodrugs | |
CN113166188A (zh) | 两性霉素b肽衍生物 | |
CN114515339B (zh) | 针对生长抑素受体的多肽偶联药物及其应用 | |
NZ533849A (en) | Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon | |
CN117106035B (zh) | 一种肿瘤靶向多肽、多肽偶联药物及制备与应用 | |
CN117106033A (zh) | 一种美登素-多肽偶联物、其制备方法及应用 | |
CN103665106A (zh) | 抗肿瘤多肽及其制备方法和应用 | |
RU2800137C1 (ru) | Конъюгат антитело-лекарственное средство, промежуточное соединение для его получения, способ его получения и его применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211116 Address after: 510515 room B502, 5 / F, building 2, No. 6, Xinrui Road, Huangpu District, Guangzhou, Guangdong Province Patentee after: GUANGZHOU YUEMEI MEDICINE TECHNOLOGY Co.,Ltd. Address before: 510515 No. 1023, shatai South Road, Baiyun District, Guangzhou, Guangdong Patentee before: Southern Medical University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220309 Address after: 528300 No. 818, floor 8, building 17, Shunlian Machinery City, Xingye 4th Road, Guanglong Industrial Park, Chihua neighborhood committee, Chencun Town, Shunde District, Foshan City, Guangdong Province Patentee after: Foshan Chenkang Biotechnology Co.,Ltd. Address before: 510515 room B502, 5 / F, building 2, No. 6, Xinrui Road, Huangpu District, Guangzhou, Guangdong Province Patentee before: GUANGZHOU YUEMEI MEDICINE TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230109 Address after: Room B502, Floor 5, Building 2, No. 6, Xinrui Road, Huangpu District, Guangzhou, Guangdong, 510530 Patentee after: Guangdong Chenkang Biotechnology Co.,Ltd. Address before: 528300 No. 818, floor 8, building 17, Shunlian Machinery City, Xingye 4th Road, Guanglong Industrial Park, Chihua neighborhood committee, Chencun Town, Shunde District, Foshan City, Guangdong Province Patentee before: Foshan Chenkang Biotechnology Co.,Ltd. |